Cargando…
Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208168/ https://www.ncbi.nlm.nih.gov/pubmed/34150656 http://dx.doi.org/10.3389/fonc.2021.687841 |
| _version_ | 1783708895362940928 |
|---|---|
| author | Li, Bo Zhao, Xin Zhang, Lei Cheng, Wen |
| author_facet | Li, Bo Zhao, Xin Zhang, Lei Cheng, Wen |
| author_sort | Li, Bo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8208168 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82081682021-06-17 Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin Li, Bo Zhao, Xin Zhang, Lei Cheng, Wen Front Oncol Oncology Frontiers Media S.A. 2021-06-02 /pmc/articles/PMC8208168/ /pubmed/34150656 http://dx.doi.org/10.3389/fonc.2021.687841 Text en Copyright © 2021 Li, Zhao, Zhang and Cheng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Li, Bo Zhao, Xin Zhang, Lei Cheng, Wen Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin |
| title | Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin |
| title_full | Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin |
| title_fullStr | Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin |
| title_full_unstemmed | Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin |
| title_short | Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin |
| title_sort | corrigendum: emodin interferes with akt1-mediated dna damage and decreases resistance of breast cancer cells to doxorubicin |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208168/ https://www.ncbi.nlm.nih.gov/pubmed/34150656 http://dx.doi.org/10.3389/fonc.2021.687841 |
| work_keys_str_mv | AT libo corrigendumemodininterfereswithakt1mediateddnadamageanddecreasesresistanceofbreastcancercellstodoxorubicin AT zhaoxin corrigendumemodininterfereswithakt1mediateddnadamageanddecreasesresistanceofbreastcancercellstodoxorubicin AT zhanglei corrigendumemodininterfereswithakt1mediateddnadamageanddecreasesresistanceofbreastcancercellstodoxorubicin AT chengwen corrigendumemodininterfereswithakt1mediateddnadamageanddecreasesresistanceofbreastcancercellstodoxorubicin |